Literature DB >> 6146932

Continuous in vitro generation of multipotential stem cell clones from src-infected cultures.

E Spooncer, D Boettiger, T M Dexter.   

Abstract

A molecular recombinant of Rous sarcoma virus and murine amphotropic leukaemia virus, src(MoMuLV), where the avian src oncogene has been placed under the influence of a murine virus promoter sequence, has been reported. Infection of long-term marrow cultures with this virus led to a dramatic change in the relative numbers of stem cells, granulocyte-macrophage progenitor cells and mature cells found in normal haematopoietic cell development. However, although the balance between self-renewal, differentiation and development was disturbed, injection of the cultured cells into irradiated syngeneic recipients did not lead to the development of leukaemia. Thus, although the control had been 'loosened', the host regulatory mechanisms were sufficient to impose a restraint on unlimited growth of the cells. We now show that the stem cells from the src-infected cultures show a remarkably increased capacity for self-renewal in vitro in situations which are inimical to the maintenance of self-renewal in normal uninfected stem cells and that self-renewal/differentiation can be modified by the culture conditions.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6146932     DOI: 10.1038/310228a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  18 in total

1.  Immunoglobulin heavy-chain and CD3 delta-chain gene enhancers are DNase I-hypersensitive in hemopoietic progenitor cells.

Authors:  A M Ford; C A Bennett; L E Healy; E Navarro; E Spooncer; M F Greaves
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

2.  Perturbed hemopoiesis and the generation of multipotential stem cell clones in src-infected bone marrow cultures is an indirect or transient effect of the oncogene.

Authors:  J A Wyke; A W Stoker; S Searle; E Spooncer; P Simmons; T M Dexter
Journal:  Mol Cell Biol       Date:  1986-03       Impact factor: 4.272

3.  Expression of the mammalian c-fes protein in hematopoietic cells and identification of a distinct fes-related protein.

Authors:  I MacDonald; J Levy; T Pawson
Journal:  Mol Cell Biol       Date:  1985-10       Impact factor: 4.272

4.  In vitro proliferation of human large granular lymphocytes with v-raf/v-myc recombinant retrovirus.

Authors:  S Peppoloni; E Blasi; J R Ortaldo; U R Rapp; C Riccardi; L Varesio
Journal:  Experientia       Date:  1988-12-01

Review 5.  Regulation of erythroid cell-specific gene expression during erythropoiesis.

Authors:  P R Harrison; M Plumb; J Frampton; D Llewellyn; J Chester; I Chambers; K MacLeod; J Fleming; J O'Prey; M Walker
Journal:  Br J Cancer Suppl       Date:  1988-12

6.  Disconnection of genes coding for self-renewal and differentiation: a possible mechanism of diversity in acute myeloid leukemias.

Authors:  H von Melchner; K Höffken
Journal:  Blut       Date:  1985-05

7.  Regulation of the myeloperoxidase enhancer binding proteins Pu1, C-EBP alpha, -beta, and -delta during granulocyte-lineage specification.

Authors:  A M Ford; C A Bennett; L E Healy; M Towatari; M F Greaves; T Enver
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

8.  Developmentally-related changes in surface membrane glycopeptides of murine haemopoietic cells.

Authors:  J T Gallagher; A J Morris; T M Dexter
Journal:  Biochem J       Date:  1987-03-15       Impact factor: 3.857

9.  A dominant negative retinoic acid receptor blocks neutrophil differentiation at the promyelocyte stage.

Authors:  S Tsai; S J Collins
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-01       Impact factor: 11.205

10.  Selectable retrovirus vectors encoding Friend virus gp55 or erythropoietin induce polycythemia with different phenotypic expression and disease progression.

Authors:  N Ahlers; N Hunt; U Just; C Laker; W Ostertag; J Nowock
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.